Literature DB >> 27592089

Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.

L B Dustin1, B Bartolini2, M R Capobianchi2, M Pistello3.   

Abstract

Hepatitis C virus (HCV) is a major global health burden accounting for around 170 million chronic infections worldwide. Since its discovery, which dates back to about 30 years ago, many details of the viral genome organization and the astonishing genetic diversity have been unveiled but, owing to the difficulty of culturing HCV in vitro and obtaining fully susceptible yet immunocompetent in vivo models, we are still a long way from the full comprehension of viral life cycle, host cell pathways facilitating or counteracting infection, pathogenetic mechanisms in vivo, and host defences. Here, we illustrate the viral life cycle into cells, describe the interplay between immune and genetic host factors shaping the course of infection, and provide details of the molecular approaches currently used to genotype, monitor replication in vivo, and study the emergence of drug-resistant viral variants.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. All rights reserved.

Entities:  

Keywords:  Broadly reactive neutralizing antibodies; Cell culture-derived HCV; Direct antiviral agents; Drug resistance; Genotype; Hepatitis C virus; Host response; Pathogenesis; Quantitative molecular assays; monitoring drug resistance

Mesh:

Substances:

Year:  2016        PMID: 27592089      PMCID: PMC5627509          DOI: 10.1016/j.cmi.2016.08.025

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  88 in total

1.  Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection.

Authors:  Ryosuke Suzuki; Kenji Saito; Takanobu Kato; Masayuki Shirakura; Daisuke Akazawa; Koji Ishii; Hideki Aizaki; Yumi Kanegae; Yoshiharu Matsuura; Izumu Saito; Takaji Wakita; Tetsuro Suzuki
Journal:  Virology       Date:  2012-06-22       Impact factor: 3.616

Review 2.  HCV in 2015: Advances in hepatitis C research and treatment.

Authors:  Barbara Rehermann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-01-21       Impact factor: 46.802

Review 3.  Natural killer cells and hepatitis C: action and reaction.

Authors:  Kuldeep Cheent; Salim I Khakoo
Journal:  Gut       Date:  2010-09-28       Impact factor: 23.059

Review 4.  Regulation of hepatic innate immunity by hepatitis C virus.

Authors:  Stacy M Horner; Michael Gale
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 5.  Hepatitis C treatment: the data flood goes on-an update from the liver meeting 2014.

Authors:  Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2015-01-07       Impact factor: 22.682

Review 6.  The role of resistance in HCV treatment.

Authors:  Johannes Vermehren; Christoph Sarrazin
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-08       Impact factor: 3.043

Review 7.  Immune control and failure in HCV infection--tipping the balance.

Authors:  Lynn B Dustin; Siobhán B Cashman; Stephen M Laidlaw
Journal:  J Leukoc Biol       Date:  2014-07-11       Impact factor: 4.962

8.  HCV NS3 quasispecies in liver and plasma and dynamics of telaprevir-resistant variants in breakthrough patients assessed by UDPS: A case study.

Authors:  Barbara Bartolini; Marina Selleri; Anna Rosa Garbuglia; Emanuela Giombini; Chiara Taibi; Raffaella Lionetti; Gianpiero D'Offizi; Maria R Capobianchi
Journal:  J Clin Virol       Date:  2015-07-30       Impact factor: 3.168

9.  Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains.

Authors:  P Trémeaux; A Caporossi; C Ramière; E Santoni; N Tarbouriech; M-A Thélu; K Fusillier; L Geneletti; O François; V Leroy; W P Burmeister; P André; P Morand; S Larrat
Journal:  Clin Microbiol Infect       Date:  2016-01-28       Impact factor: 8.067

10.  Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.

Authors:  Eva Dazert; Christoph Neumann-Haefelin; Stéphane Bressanelli; Karen Fitzmaurice; Julia Kort; Jörg Timm; Susan McKiernan; Dermot Kelleher; Norbert Gruener; John E Tavis; Hugo R Rosen; Jaqueline Shaw; Paul Bowness; Hubert E Blum; Paul Klenerman; Ralf Bartenschlager; Robert Thimme
Journal:  J Clin Invest       Date:  2009-01-12       Impact factor: 14.808

View more
  25 in total

1.  COVID-19 infection with keratitis as the first clinical manifestation.

Authors:  Dong-Mei Zuo; Lin-Ping Xue; Heng Fan; Sheng-Li Yang; Liang-Chang Li; Ji-Hong Luo; Shuo Zang; Jun Xiao
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

2.  The impact of nucleic acid testing as a blood donor screening method in transfusion-associated hepatitis C among children with bleeding disorders in Indonesia: a single-center experience.

Authors:  Novie Amelia Chozie; Melati Arum Satiti; Damayanti Rusli Sjarif; Hanifah Oswari; Ni Ken Ritchie
Journal:  Blood Res       Date:  2022-05-30

3.  SARS-CoV-2 infection in a pediatric acute leukemia patient on chemotherapy and concurrent sofosbuvir/velpatasvir for HCV.

Authors:  Amitabh Singh; Akriti Gera; Aroonima Misra; Sumit Mehndiratta
Journal:  Am J Blood Res       Date:  2021-06-15

Review 4.  Mitochondrial Proteins Coded by Human Tumor Viruses.

Authors:  Ilaria Cavallari; Gloria Scattolin; Micol Silic-Benussi; Vittoria Raimondi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

Review 5.  Cardiovascular Involvement in Chronic Hepatitis C Virus Infections - Insight from Novel Antiviral Therapies.

Authors:  Wolfgang Poller; Arash Haghikia; Mario Kasner; Ziya Kaya; Udo Bavendiek; Heiner Wedemeier; Hans-Jörg Epple; Carsten Skurk; Ulf Landmesser
Journal:  J Clin Transl Hepatol       Date:  2018-01-26

Review 6.  Role of the Guanine Nucleotide Exchange Factor GBF1 in the Replication of RNA Viruses.

Authors:  José L Martínez; Carlos F Arias
Journal:  Viruses       Date:  2020-06-24       Impact factor: 5.048

Review 7.  Humanized Mouse Models for the Study of Hepatitis C and Host Interactions.

Authors:  Kylie Su Mei Yong; Zhisheng Her; Qingfeng Chen
Journal:  Cells       Date:  2019-06-17       Impact factor: 6.600

8.  Characterization of Hepatitis C Virus IRES Quasispecies - From the Individual to the Pool.

Authors:  Václav Vopálenský; Anas Khawaja; Luděk Rožnovský; Jakub Mrázek; Tomáš Mašek; Martin Pospíšek
Journal:  Front Microbiol       Date:  2018-04-24       Impact factor: 5.640

9.  Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase.

Authors:  Minchen Chien; Thomas K Anderson; Steffen Jockusch; Chuanjuan Tao; Shiv Kumar; Xiaoxu Li; James J Russo; Robert N Kirchdoerfer; Jingyue Ju
Journal:  bioRxiv       Date:  2020-03-20

10.  Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19.

Authors:  Minchen Chien; Thomas K Anderson; Steffen Jockusch; Chuanjuan Tao; Xiaoxu Li; Shiv Kumar; James J Russo; Robert N Kirchdoerfer; Jingyue Ju
Journal:  J Proteome Res       Date:  2020-08-05       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.